The London Borough of Sutton has launched a tender for a Development Partner for The London Cancer Hub.

The Hub is envisaged as a world-leading cancer innovation centre that will provide opportunities for scientists, clinicians, and innovative companies. The estimated total investment is GBP350 million (US$450.6 million).

It will be developed across a 4.8-hectare site in south-west London, within the 21-acre The London Cancer Campus, which includes land owned by Institute of Cancer Research (ICR) and The Royal Marsden NHS Foundation Trust, a cancer treatment specialist.

The site acquired for the Hub has the potential to accommodate up to 100 000m2 of space.  

Interested participants are invited to complete a selection questionnaire by 11 March 2019. Following this, between three and five respondents will be invited to submit proposals for the project. Invitations are scheduled to be dispatched on 23 April 2019.

Prospective development partners should have experience in delivering high quality commercially led research and development and life science accommodation.